Filtered By:
Management: Electronic Health Records (EHR)
Vaccination: Cancer Vaccines
This page shows you your search results in order of date.
Order by Relevance | Date
Total 42 results found since Jan 2013.
The Scottish COVID Cancer Immunity Prevalence Study: A Longitudinal Study of SARS-CoV-2 Immune Response in Patients Receiving Anti-Cancer Treatment
CONCLUSION: This is the largest on-going longitudinal real-world dataset of patients undergoing ACT during the early stages of the COVID-19 pandemic. This preliminary analysis demonstrates that patients with solid tumors undergoing ACT have high protection from SARS-CoV-2 infection following COVID-19 vaccination. The SCCAMP study will evaluate long-term COVID-19 antibody trends, focusing on specific ACTs and patient subgroups.PMID:36719033 | DOI:10.1093/oncolo/oyac257
Source: The Oncologist - January 31, 2023 Category: Cancer & Oncology Authors: Karin Purshouse John P Thomson Mah éva Vallet Lorna Alexander Isaac Bonisteel Maree Brennan David A Cameron Jonine D Figueroa Elizabeth Furrie Pamela Haig Mattea Heck Hugh McCaughan Paul Mitchell Heather McVicars Lorraine Primrose Ines Silva Kate Templet Source Type: research
Impact of HPV vaccination on HPV infection and cervical related disease burden in real-world settings (HPV-RWS): protocol of a prospective cohort
This study has been retrospectively registered on clinicaltrials.gov (NCT05341284) on April 22, 2022.PMID:36401179 | DOI:10.1186/s12889-022-14474-1
Source: Cancer Control - November 19, 2022 Category: Cancer & Oncology Authors: Zhike Liu Pei Li Xueyang Zeng Xiaoying Yao Yexiang Sun Hongbo Lin Peng Shen Feng Sun Siyan Zhan Source Type: research
Weekly Overseas Health IT Links – 15th October, 2022.
This article uses the one that divides providers into groups depending on the life cycle stage the clinic is at the given moment. According to this classification, medical providers fall into three groups:BeginnersGrowing clinicsWell-established providersHealth care providers are business entities, so their life cycle, like that of any business, consists of the early stage or launch, growth and maturity. At each stage, providers have different priorities and goals, and the choice of medical software solutions should be made accordingly.Medical software for beginnersThe launch phase can be tough. At this stage, the profits ...
Source: Australian Health Information Technology - October 15, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Immune-Related Adverse Events Among COVID-19-Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade
CONCLUSIONS: These findings should reassure providers that COVID-19 vaccination during ICI therapy is safe and efficacious.PMID:36240845 | DOI:10.6004/jnccn.2022.7048
Source: Cancer Control - October 14, 2022 Category: Cancer & Oncology Authors: Adam J Widman Bevin Cohen Vivian Park Tara McClure Jedd Wolchok Mini Kamboj Source Type: research
Weekly Overseas Health IT Links –1st October, 2022.
This article details information required for integration into EHRs to build personalized treatment plans and develop successful SDOH programs that provide resources and support for patients in need. In addition, successful SDOH programs implemented by Kaiser Permanente and Boston Medical Center showcase how supporting clinicians with real-time SDOH data can lead to patient-centric care. Create a 360-Degree Patient View Through TechnologyThe Office of the National Coordinator for Health Information Technology (ONC)indicatesthat the “collection, documentation, reporting, access, and use of SDOH data … can be used t...
Source: Australian Health Information Technology - October 1, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales
CONCLUSIONS: High relative incidence of vascular events soon after COVID-19 diagnosis declines more rapidly for arterial thromboses than VTEs. However, incidence remains elevated up to 49 weeks after COVID-19 diagnosis. These results support policies to prevent severe COVID-19 by means of COVID-19 vaccines, early review after discharge, risk factor control, and use of secondary preventive agents in high-risk patients.PMID:36121907 | DOI:10.1161/CIRCULATIONAHA.122.060785
Source: Cancer Control - September 19, 2022 Category: Cancer & Oncology Authors: Rochelle Knight Venexia Walker Samantha Ip Jennifer A Cooper Thomas Bolton Spencer Keene Rachel Denholm Ashley Akbari Hoda Abbasizanjani Fatemeh Torabi Efosa Omigie Sam Hollings Teri-Louise North Renin Toms Xiyun Jiang Emanuele Di Angelantonio Spiros Dena Source Type: research
Health Indicators as a Measure of Individual Health Status: Public Perspectives
CONCLUSIONS: This study provides a baseline for prioritizing 29 health indicators, which can be used by electronic health records or personal health record system designers or developers to determine what can be included in the systems to capture an individual's health status. Currently, self-rated health status is used predominantly. Additionally, this study provides a foundation for tracking and measuring preventive healthcare services more accurately and developing an individual health status index.PMID:35623051 | DOI:10.2196/38099
Source: Topics in HIV Medicine - May 27, 2022 Category: Infectious Diseases Authors: Temiloluwa Sokoya Yuchun Zhou Sebastian Diaz Timothy Law Lina Himawan Francisca Lekey Lu Shi Ronald W Gimbel Xia Jing Source Type: research
